109 completed, 34 unknown, 20 terminated, 13 withdrawn. 187 Phase 2, 35 Phase 3, 19 Phase 1.
Follow Placebos: new trials by email Literature Review of Placebos trials Research Report on Placebos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis BAT4406F, Placebos - Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 / Phase 3 | Recruiting | Bio-Thera Solutions | 192 | 2025-10-26 | 2026-04-03 |
| A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis apabetalone, Placebos - Kidney Failure, Chronic | Phase 1 / Phase 2 | Not yet recruiting | Resverlogix Corp | 44 | 2024-11-22 | 2023-11-15 |
| The Effects of Metformin on Morbidity and Mortality in Elderly Patients Metformin, Placebos - Burns | Phase 2 | Not yet recruiting | Hamilton Health Sciences Corporation | 250 | 2024-11-01 | 2024-10-02 |
| Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo Methotrexate, Placebos - Vitiligo | Phase 2 | Completed | University Hospital, Bordeaux | 32 | 2023-05-23 | 2026-05-22 |
| Dexmedetomidine and HIPEC Dexmedetomidine, Placebos - Inflammation, Cancer | Phase 2 / Phase 3 | Unknown | University of British Columbia | 20 | 2023-03-01 | 2022-11-03 |
| Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease Clenbuterol, Placebos - Pompe Disease (Late-onset) | Phase 2 | Withdrawn | Duke University | 2023-01-01 | 2022-08-17 | |
| A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery. HR18042 tablets, Tramadol hydrochloride SR Tablets, Placebos - Pain | Phase 2 | Terminated | Jiangsu HengRui Medicine Co., Ltd. | 110 | 2022-08-11 | 2025-06-26 |
| Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure | Phase 2 / Phase 3 | Unknown | Erasme University Hospital | 60 | 2021-12-30 | 2021-08-02 |
| Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD) Zoledronic Acid 5 MG in 5 ML Injection, Placebos - Neovascular Age-related Macular Degeneration | Phase 2 | Completed | Oslo University Hospital | 40 | 2021-10-25 | 2024-04-05 |
| Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair Testosterone cypionate, Placebos - Rotator Cuff Tears | Phase 2 / Phase 3 | Withdrawn | Orthopedic Institute, Sioux Falls, SD | 2021-08-01 | 2022-03-15 | |
| Benralizumab Initiated During Severe Asthma Attack Benralizumab 30 MG/ML [Fasenra], Placebos - Asthma Attack, Asthma | Phase 2 | Unknown | Singapore General Hospital | 128 | 2021-06-02 | 2021-07-23 |
| Study of CAD-1883 for Spinocerebellar Ataxia CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 2 | Withdrawn | Cadent Therapeutics | 2021-06-01 | 2021-04-08 | |
| Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients 16mg,KB, Placebos - Sepsis | Phase 2 | Unknown | Tianjin Chasesun Pharmaceutical Co., LTD | 424 | 2021-05-15 | 2024-04-10 |
| Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients Sulfasalazine, Placebos - Breast Cancer, Chronic Pain Due to Malignancy (Finding) | Phase 2 | Completed | University of Arizona | 7 | 2021-05-03 | 2025-01-09 |
| Melatonin on Clock Genes in Parkinson's Disease Melatonin, Placebos - Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Instituto Mexicano del Seguro Social | 2021-05-01 | 2020-08-04 | |
| Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age Placebos, 20mg sodium nitrite tid - Aging, Sedentary Lifestyle | Phase 2 | Completed | Gladwin, Mark, MD | 64 | 2021-04-23 | 2024-10-10 |
| Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 Placebos, Leronlimab (700mg) - Coronavirus Disease 2019 | Phase 2 | Completed | CytoDyn, Inc. | 56 | 2021-03-01 | 2024-04-11 |
| Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects 15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959 - Alzheimer Disease | Phase 2 | Completed | T3D Therapeutics, Inc. | 250 | 2021-03-01 | 2024-07-19 |
| Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention eRapa, Placebos - Non-muscle Invasive Bladder Cancer | Phase 2 | Active not recruiting | Robert Svatek | 166 | 2021-01-25 | 2026-06-03 |
| Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers Placebos, Baclofen 5 mg, Baclofen 10mg - Acute Pain, Analgesia | Phase 2 / Phase 3 | Terminated | University of Alabama at Birmingham | 19 | 2021-01-21 | 2026-01-07 |
Showing 20 of 187. Sign in to see all of them.
COVID-19 (7) · Non-alcoholic Fatty Liver Disease (5) · Inflammation (4) · Obesity (4) · Acute Pain (3) · Alzheimer Disease (3) · Arthritis, Rheumatoid (3) · Asthma (3) · Breast Neoplasms (3) · Depression (3) · Epilepsy (3) · Neoplasms (3) · Acquired Immunodeficiency Syndrome (2) · Amyotrophic Lateral Sclerosis (2) · Coronavirus Infections (2)
John Paul II Hospital, Krakow (3) · Icahn School of Medicine at Mount Sinai (2) · Jiangsu HengRui Medicine Co., Ltd. (2) · Johns Hopkins Bloomberg School of Public Health (2) · Johns Hopkins University (2) · Mayo Clinic (2) · Oslo University Hospital (2) · Revimmune (2) · State University of New York - Downstate Medical Center (2) · Sun Yat-sen University (2) · The Cleveland Clinic (2) · Vanderbilt University Medical Center (2) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (2) · Virginia Commonwealth University (2) · Yale-NUS College (2)
United States (73) · China (24) · France (10) · Canada (8) · Spain (7) · Czechia (6) · Poland (6) · Netherlands (5) · Denmark (4) · Germany (4) · Italy (4) · Mexico (4) · Norway (4) · Sweden (4) · Switzerland (4)
Deven V Parmar, MD,FACP,FCP (2) · James Murrough, MD, PhD (2) · Paul C Cremer, M. D. (2) · Aldo Sgaravatti, MD (1) · Allison R Eckard, MD (1) · Amanda C Palmer, PhD (1) · Anat Berkovitch, resident (1) · Andrew S Huhn, PhD (1) · Angelique ME Spoelstra-de Man, Dr. (1) · Angelo Tremblay, Ph.D (1) · Anil Bhansali, DM (1) · Antonio Abbate, MD, PhD (1)
PMID 33754144, PMID 10427152, PMID 10811917, PMID 12050214, PMID 16450381, PMID 16611468, PMID 16984654, PMID 17138963, PMID 17492050, PMID 19700350, PMID 19720908, PMID 19858734, PMID 20012748, PMID 20417240, PMID 20506391, PMID 20739336, PMID 21300635, PMID 21981277, PMID 22406244, PMID 22983830, PMID 23047939, PMID 23204220, PMID 23393105, PMID 23404447, PMID 23620700, PMID 24126568, PMID 24256396, PMID 24374976, PMID 24445955, PMID 24485867, PMID 25445859, PMID 25606785, PMID 26647939, PMID 27447617, PMID 27609406, PMID 27609408, PMID 28673265, PMID 28749480, PMID 29294429, PMID 29718383, PMID 29982218, PMID 30713498, PMID 30904852, PMID 31024734, PMID 31268126, PMID 31310686, PMID 31356217, PMID 31824943, PMID 31997819, PMID 32135138
2018 (5), 2017 (4), 2015 (2), 2016 (2), 2004 (1), 2019 (1), K23DK106448 (1), P30CA006973 (1), P50AA012870 (1), P50CA058236 (1), R01AG051596 (1), R01AG058883 (1), R01AG061122 (1), R01CA190610 (1), R01CA252057 (1)